Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prevalence of pre-existing neutralizing antibodies to AAV5 and AAV8 in patients with Wilson's disease.

Molecular therapy. Advances·2026
Same author

ANXA11 suppression restores muscular function in the mdx mouse model of Duchenne muscular dystrophy (DMD).

Nature communications·2026
Same author

Pyramidal signs in Huntington's disease: An early clinical indicator associated with proximity to disease onset.

Med (New York, N.Y.)·2026
Same author

BTAF1: a key regulator of DNA end resection and predictor of chemotherapy sensitivity in gastric cancer.

Cell death and differentiation·2026
Same author

Heterozygous Loss-of-Function Variants of KCNJ10 Cause Paroxysmal Kinesigenic Dyskinesia.

Movement disorders : official journal of the Movement Disorder Society·2026
Same author

More than microglial depletion: PLX5622 activates the hepatic constitutive androstane receptor to alter anesthesia and addiction.

Neuron·2026

Related Experiment Video

Updated: Mar 6, 2026

Positron Emission Tomography Using 64-Copper as a Tracer for the Study of Copper-Related Disorders
06:52

Positron Emission Tomography Using 64-Copper as a Tracer for the Study of Copper-Related Disorders

Published on: April 28, 2023

2.1K

Wilson's Disease in China.

Juan-Juan Xie1, Zhi-Ying Wu2

  • 1Department of Neurology and Research Center of Neurology in the Second Affiliated Hospital, and the Collaborative Innovation Center for Brain Science, Zhejiang University School of Medicine, Hangzhou, 310009, China.

Neuroscience Bulletin
|March 8, 2017
PubMed
Summary
This summary is machine-generated.

Wilson's disease (WD) is a genetic copper metabolism disorder more common in China. Early diagnosis and treatment improve prognosis, but tailored Chinese patient regimens are needed.

Keywords:
CopperEpidemiologyManagementPathogenesisWilson’s Disease

More Related Videos

Author Spotlight: Investigating the Potential of Chinese Herbal Medicinal Active Dioscin in Treating IgA Nephropathy
14:18

Author Spotlight: Investigating the Potential of Chinese Herbal Medicinal Active Dioscin in Treating IgA Nephropathy

Published on: October 13, 2023

1.9K
Ion Mobility-Mass Spectrometry Techniques for Determining the Structure and Mechanisms of Metal Ion Recognition and Redox Activity of Metal Binding Oligopeptides
11:04

Ion Mobility-Mass Spectrometry Techniques for Determining the Structure and Mechanisms of Metal Ion Recognition and Redox Activity of Metal Binding Oligopeptides

Published on: September 7, 2019

9.9K

Related Experiment Videos

Last Updated: Mar 6, 2026

Positron Emission Tomography Using 64-Copper as a Tracer for the Study of Copper-Related Disorders
06:52

Positron Emission Tomography Using 64-Copper as a Tracer for the Study of Copper-Related Disorders

Published on: April 28, 2023

2.1K
Author Spotlight: Investigating the Potential of Chinese Herbal Medicinal Active Dioscin in Treating IgA Nephropathy
14:18

Author Spotlight: Investigating the Potential of Chinese Herbal Medicinal Active Dioscin in Treating IgA Nephropathy

Published on: October 13, 2023

1.9K
Ion Mobility-Mass Spectrometry Techniques for Determining the Structure and Mechanisms of Metal Ion Recognition and Redox Activity of Metal Binding Oligopeptides
11:04

Ion Mobility-Mass Spectrometry Techniques for Determining the Structure and Mechanisms of Metal Ion Recognition and Redox Activity of Metal Binding Oligopeptides

Published on: September 7, 2019

9.9K

Area of Science:

  • Genetics
  • Metabolic Disorders
  • Biochemistry

Background:

  • Wilson's disease (WD) is an autosomal recessive genetic disorder affecting copper metabolism.
  • The ATP7B gene encodes a P-type ATPase crucial for copper excretion and holoceruloplasmin synthesis.
  • WD incidence is higher in China, with diverse clinical presentations leading to frequent misdiagnosis.

Purpose of the Study:

  • To establish the first Chinese spectrum of ATP7B disease-causing mutations.
  • To highlight the importance of genetic diagnosis in China for Wilson's disease.
  • To advocate for the development of WD treatment regimens specific to Chinese patients.

Main Methods:

  • Genetic analysis of ATP7B gene variants in Chinese patients.
  • Review of existing clinical data and treatment experiences in China.
  • Comparative analysis of Chinese WD patient data with international findings.

Main Results:

  • The first comprehensive spectrum of ATP7B mutations causing WD in China has been established.
  • Genetic diagnosis is increasingly routine in China for Wilson's disease.
  • Current treatments in China rely heavily on expert experience and international evidence.

Conclusions:

  • Early diagnosis and chelation therapy offer a good prognosis for most Wilson's disease patients.
  • There is a critical need for clinical trials and development of WD treatment regimens tailored for the Chinese population.
  • Understanding the genetic landscape and clinical characteristics of WD in China is essential for improving patient outcomes.